AMSIY News Alert Arcelormittal ADR (AMSIY) 3.1600 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Arcelormittal ADR (AMSIY) 3.1600 $AMSIY

Fiat Industrial-CNH Merger Approved - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 10, 7:50AM CDT
Fiat Industrial recently inched a step closer to fully merge with CNH after almost all of its shareholders voted in favor of the cash-and-share merger offer to buy the remaining 12% ownership stake in the latter.

Schnitzer Steel Misses in 3Q, Profit Slides - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 02, 7:20AM CDT
Schnitzer Steel's third-quarter revenues and earnings missed Zacks Consensus Estimate.

Scnhitzer Provides 3Q Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 30, 5:00PM CDT
Schnitzer Steel Industries, Inc. has announced its guidance for the third quarter of fiscal 2013.

Neutral Rec Maintained on Gerdau - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 29, 4:40PM CDT
We recently maintained our Neutral recommendation on Gerdau S.A. , one of the leading steel producers in Brazil.

Recognition for AK Steel's Ohio Plant - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 28, 1:40PM CDT
AK Steel's Walbridge plant has gained recognition for its exceptional safety performance.

Charges Hit ArcelorMittal in 4Q - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 07, 9:10AM CST
Steel bellwether ArcelorMittal posted a net loss of $4 billion or $2.58 per share in the fourth quarter of 2012 compared with a net loss of $1 billion or 65 cents per share a year ago.

Mechel's Unit Buys Vanino Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 06, 3:00PM CST
Mechel OAO announced that its logistics subsidiary Mecheltrans OOO has acquired a 21.64% stake at Port Vanino for 4.57 billion rubles (around $152 million) from one of the port's minor shareholders, a subsidiary of the company En+.

POSCO Posts Weak 2012 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 30, 9:20AM CST
Korean steel maker, POSCO reported its fourth quarter and 2012 financial results on Jan 29, 2013. Results were weak in 2012 as net income fell 35.8% year over year to KRW 2,386 billion (US$2.2 billion) or KRW 27,347 per share (US6.30 per ADR).

Mixed 4Q for Nucor Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 29, 1:47PM CST
Steel giant Nucor Corporation's adjusted (excluding special items) earnings was 31 cents per share in the fourth quarter of 2012, ahead of the Zacks Consensus Estimate of 29 cents.

Mechel Restarts Bluestone Facility - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 29, 11:40AM CST
Russian miner Mechel OAO announced the resumption of operations at some of its Bluestone mining facilities in West Virginia, U.S.

Mechel Sells Part of Vanino Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 22, 11:40AM CST
Mechel OAO has announced that it has sold a part of its 73.3% stake (55% of share capital) in Vanino Sea Trade Port OAO, which it bought from the Russian government and foreign investors.

USAP Posts 4Q Prelim Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 21, 11:30AM CST
Universal Stainless & Alloy Products, Inc. has released its preliminary results for the fourth quarter of 2012.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading